Sharps Technology (STSS) vs. Its Competitors Critical Review

Sharps Technology (NASDAQ:STSS) is one of 233 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its competitors? We will compare Sharps Technology to similar businesses based on the strength of its dividends, profitability, analyst recommendations, risk, institutional ownership, valuation and earnings.

Profitability

This table compares Sharps Technology and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-102.25%	-72.97%
Sharps Technology Competitors	-627.86%	-133.35%	-27.87%

Institutional and Insider Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 48.5% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 14.1% of Sharps Technology shares are held by insiders. Comparatively, 15.2% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Sharps Technology has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Sharps Technology’s competitors have a beta of 0.58, meaning that their average stock price is 42% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Sharps Technology and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
Sharps Technology Competitors	1673	4453	8636	232	2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 28.34%. Given Sharps Technology’s competitors higher probable upside, analysts plainly believe Sharps Technology has less favorable growth aspects than its competitors.

Valuation and Earnings

This table compares Sharps Technology and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sharps Technology	N/A	-$9.84 million	-0.45
Sharps Technology Competitors	$1.03 billion	$3.54 million	-4,470.40

Sharps Technology’s competitors have higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Sharps Technology competitors beat Sharps Technology on 6 of the 9 factors compared.

Sharps Technology Company Profile

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.